A Phase II Study of Altretamine (HEX) for the Treatment of Metastatic Renal Cell Cancer

Abstracts/Posters/Presentations:

• McClean J, Loehrer P, Picus J, Ansari R, Mitchell E, Reynolds R, Capizzi R. A Phase II Study of Altretramine for the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group, Walther Cancer Institute, and US Bioscience Trial GU91-1. Accepted to the ASCO Annual Meeting, May 14th – 17th, 1994, Dallas, Texas.

Manuscripts/Articles:

• Zon R, McClean J, Helman D, Ansari R, Picus J, Sandler A, Williams S, Loehrer Sr P. Altretamine For the Treatment of Metastatic Renal Cell Carcinoma: A Hoosier Oncology Group Trial GU91-1. Invest New Drugs 19(3):229-231, August 2001. See abstract.